Testing a GBS vaccine with and without Tdap in healthy women
Part of Infections clinical trials.
This trial tests a new vaccine to prevent Group B Strep (GBS) infection, given alone or with the Tdap vaccine. It aims to see if the combination is safe and works well in healthy women aged 18 to 49.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 49 years old
- You have a body mass index (BMI) between 17.5 and 40
- You are generally healthy or have well-managed conditions
- You are not pregnant, not planning pregnancy, and use effective birth control or are not able to become pregnant
- You have not had a GBS vaccine, Tdap vaccine in the last 5 years, or any vaccine in the last 30 days
- You are not taking long-term steroids or immune-suppressing medicines
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a vaccine against Group B Streptococcus (GBS) during pregnancy to see if it can protect newborns from infection. Healthy pregnant women with a single baby can join.
This study tests blood samples from women who received a Group B Streptococcus (GBS) vaccine during pregnancy to ensure the vaccine is working safely and correctly. Researchers want to check your immune response and confirm the vaccine quality.
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
This study tests a new vaccine designed to protect against Group A Strep bacteria. It will check how safe the vaccine is and how well it boosts your immune system. Healthy young adults between 18 and 25 years old may be eligible.
This trial tests a new meningitis vaccine (GNG-DE) to see how well it works compared to a vaccine already on the market. It might help protect you or your child from meningococcal disease.
This trial tests a new vaccine designed to protect against gonorrhea, a common sexually transmitted infection. The study checks how safe the vaccine is and how well it trains the immune system to fight the bacteria.
Hear when a new Streptococcus Agalactiae Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.